Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'Euphoria' releases Season 3 trailer, premiere date: Watch Rue and Laurie finally face off - 2Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- 3Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- 4Meet the Stars of the Feline World: Well known Pet Feline Varieties
- 5Congolese rape survivors search in vain for medicine after USAID cuts
- Germany's Pistorius: NATO protects Europe from Iranian missiles
- Key Little Things That Advantage Old People
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- Grasping Wrongdoings and Crimes: A Correlation
- Taco Bell debuts its Baja Blast pie, and the reactions may surprise you
- Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
- Glamour Shots once ruled the mall. I went to one of the last ones standing.
- Pick Your Favored kind of books
- Cuba fights to contain spread of mosquito-borne chikungunya virus
